"Treatment with semaglutide, at low doses, significantly reduces body weight in almost 80% of obese PCOS patients who were unresponsive to a previous lifestyle plan." - Enrico Carmina, MD This highlights how critical it is to stay consistent with treatment to achieve and maintain these results
In clinical trials, it has been tested at doses ranging from 1mg to 12mg, with a gradual titration schedule designed to reduce gastrointestinal side effects
RuBisCO detected in atmospheric aerosol RuBisCO has not been observed in atmospheric aerosol prior to this study
For starters, GLP-1 agonists can be pricey
More long-term research is needed, but studies spanning four years indicate the drugs safety
PlexusDx supports ongoing communication between you and your healthcare provider to ensure semaglutide remains safe throughout your treatment